MARKET

MRUS

MRUS

Merus
NASDAQ
44.75
-0.16
-0.36%
Closed 16:20 03/27 EDT
OPEN
45.15
PREV CLOSE
44.91
HIGH
45.15
LOW
44.10
VOLUME
234.58K
TURNOVER
0
52 WEEK HIGH
52.04
52 WEEK LOW
17.15
MARKET CAP
2.61B
P/E (TTM)
-14.9047
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at MRUS last week (0318-0322)?
Weekly Report · 3d ago
YmAbs Therapeutics (YMAB) Surges 8.2%: Is This an Indication of Further Gains?
NASDAQ · 03/20 11:37
Weekly Report: what happened at MRUS last week (0311-0315)?
Weekly Report · 03/18 11:48
Analysts Offer Insights on Healthcare Companies: Geron (GERN), Merus (MRUS) and MoonLake Immunotherapeutics (MLTX)
TipRanks · 03/11 13:10
Weekly Report: what happened at MRUS last week (0304-0308)?
Weekly Report · 03/11 11:44
Analysts Offer Insights on Healthcare Companies: Ocuphire Pharma (OCUP), Merus (MRUS) and Eli Lilly & Co (LLY)
TipRanks · 03/11 11:10
Big Pharma patent cliffs seen fueling oncology M&A this year
Big Pharma patent cliffs seen fueling oncology M&A this year. Around $182B in revenue is at risk over the next four years due to patent expirations. Cantor Fitzgerald sees between five and 17 acquisition deals for oncologists in 2014. The global market for cancer drugs is expected to grow from $180B in 2022 to $323B in 2028.
Seeking Alpha · 03/10 17:08
Wall Street Analysts Are Bullish on Top Healthcare Picks
TipRanks · 03/08 10:21
More
About MRUS
Merus NV is the Netherlands - based biotechnology company, concentrated on developing differentiating therapeutics for cancer patients. The product programs in the Merus pipeline are based on the Multiclonics format. Its products are designed to bind to multiple targets, and are manufactured with features for anti-cancer effects against the complex mechanisms that drive cancer. Company's products engage cancer antigens and harness the power of the immune system to kill tumor cells by utilizing technology platform. One of the drug zenocutuzumab (Zeno), a Biclonics antibody, concentrates on helping patients with lung, pancreatic and other types of solid tumors. The company operates in the Netherlands and United States.

Webull offers Merus NV stock information, including NASDAQ: MRUS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MRUS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading MRUS stock methods without spending real money on the virtual paper trading platform.